NO993372D0 - Substituerte 4-(6-fluor-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridin for behandling av CNS-forstyrrelser - Google Patents
Substituerte 4-(6-fluor-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridin for behandling av CNS-forstyrrelserInfo
- Publication number
- NO993372D0 NO993372D0 NO993372A NO993372A NO993372D0 NO 993372 D0 NO993372 D0 NO 993372D0 NO 993372 A NO993372 A NO 993372A NO 993372 A NO993372 A NO 993372A NO 993372 D0 NO993372 D0 NO 993372D0
- Authority
- NO
- Norway
- Prior art keywords
- tetrahydropyridine
- indol
- fluoro
- substituted
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9700895.7A GB9700895D0 (en) | 1997-01-17 | 1997-01-17 | Pharmaceutical compounds |
| PCT/GB1998/000113 WO1998031686A1 (en) | 1997-01-17 | 1998-01-14 | Substituted 4-(6-fluoro-(1h)-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of cns-disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993372L NO993372L (no) | 1999-07-08 |
| NO993372D0 true NO993372D0 (no) | 1999-07-08 |
Family
ID=10806121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993372A NO993372D0 (no) | 1997-01-17 | 1999-07-08 | Substituerte 4-(6-fluor-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridin for behandling av CNS-forstyrrelser |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20010053783A1 (es) |
| EP (1) | EP0854146B1 (es) |
| JP (1) | JPH10204090A (es) |
| KR (1) | KR20000070221A (es) |
| AR (1) | AR011422A1 (es) |
| AT (1) | ATE190617T1 (es) |
| AU (1) | AU5569298A (es) |
| CA (1) | CA2227132A1 (es) |
| CZ (1) | CZ290318B6 (es) |
| DE (1) | DE69800092T2 (es) |
| DK (1) | DK0854146T3 (es) |
| EA (1) | EA001469B1 (es) |
| ES (1) | ES2144888T3 (es) |
| GB (1) | GB9700895D0 (es) |
| GR (1) | GR3033316T3 (es) |
| HU (1) | HUP0000854A3 (es) |
| ID (1) | ID21920A (es) |
| IL (1) | IL129647A (es) |
| NO (1) | NO993372D0 (es) |
| NZ (1) | NZ335493A (es) |
| PE (1) | PE99399A1 (es) |
| PL (1) | PL334569A1 (es) |
| PT (1) | PT854146E (es) |
| SI (1) | SI0854146T1 (es) |
| SV (1) | SV1998000088A (es) |
| TR (1) | TR199901583T2 (es) |
| TW (1) | TW396156B (es) |
| WO (1) | WO1998031686A1 (es) |
| ZA (1) | ZA98300B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999010346A1 (en) * | 1997-08-22 | 1999-03-04 | Eli Lilly And Company Limited | Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands |
| GB9825413D0 (en) * | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
| GB9903784D0 (en) * | 1999-02-18 | 1999-04-14 | Lilly Co Eli | Pharmaceutical compounds |
| AR028945A1 (es) * | 2000-06-19 | 2003-05-28 | Lundbeck & Co As H | Derivados de indol |
| KR101165996B1 (ko) | 2010-04-23 | 2012-07-18 | 주식회사 녹십자 | 프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물 |
| CN105949190B (zh) * | 2016-07-04 | 2018-06-29 | 烟台凯博医药科技有限公司 | 一种制备1，8-萘啶及衍生物的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2662696A2 (fr) * | 1989-12-13 | 1991-12-06 | Rhone Poulenc Sante | Antagonistes de la serotonine, leur preparation et medicaments les contenant. |
| DK158590D0 (da) * | 1990-07-02 | 1990-07-02 | Lundbeck & Co As H | Indolderivater |
| FR2675801A1 (fr) * | 1991-04-24 | 1992-10-30 | Rhone Poulenc Rorer Sa | Piperidines, leur preparation et les medicaments les contenant. |
| DE19500689A1 (de) * | 1995-01-12 | 1996-07-18 | Merck Patent Gmbh | Indolpiperidin-Derivate |
| US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
-
1997
- 1997-01-17 GB GBGB9700895.7A patent/GB9700895D0/en active Pending
-
1998
- 1998-01-13 TW TW087100373A patent/TW396156B/zh not_active IP Right Cessation
- 1998-01-13 US US09/005,995 patent/US20010053783A1/en not_active Abandoned
- 1998-01-14 ES ES98300249T patent/ES2144888T3/es not_active Expired - Lifetime
- 1998-01-14 EP EP98300249A patent/EP0854146B1/en not_active Expired - Lifetime
- 1998-01-14 JP JP10005897A patent/JPH10204090A/ja active Pending
- 1998-01-14 SI SI9830009T patent/SI0854146T1/xx unknown
- 1998-01-14 NZ NZ335493A patent/NZ335493A/xx unknown
- 1998-01-14 EA EA199900667A patent/EA001469B1/ru not_active IP Right Cessation
- 1998-01-14 PL PL98334569A patent/PL334569A1/xx unknown
- 1998-01-14 AT AT98300249T patent/ATE190617T1/de not_active IP Right Cessation
- 1998-01-14 CZ CZ19991510A patent/CZ290318B6/cs not_active IP Right Cessation
- 1998-01-14 HU HU0000854A patent/HUP0000854A3/hu unknown
- 1998-01-14 PT PT98300249T patent/PT854146E/pt unknown
- 1998-01-14 WO PCT/GB1998/000113 patent/WO1998031686A1/en not_active Application Discontinuation
- 1998-01-14 KR KR1019997006447A patent/KR20000070221A/ko not_active Application Discontinuation
- 1998-01-14 TR TR1999/01583T patent/TR199901583T2/xx unknown
- 1998-01-14 IL IL12964798A patent/IL129647A/en not_active IP Right Cessation
- 1998-01-14 ID IDW990623A patent/ID21920A/id unknown
- 1998-01-14 DK DK98300249T patent/DK0854146T3/da active
- 1998-01-14 DE DE69800092T patent/DE69800092T2/de not_active Expired - Fee Related
- 1998-01-14 ZA ZA98300A patent/ZA98300B/xx unknown
- 1998-01-14 AU AU55692/98A patent/AU5569298A/en not_active Abandoned
- 1998-01-15 CA CA002227132A patent/CA2227132A1/en not_active Abandoned
- 1998-01-16 AR ARP980100185A patent/AR011422A1/es unknown
- 1998-07-09 PE PE1998000607A patent/PE99399A1/es not_active Application Discontinuation
- 1998-07-16 SV SV1998000088A patent/SV1998000088A/es unknown
-
1999
- 1999-07-08 NO NO993372A patent/NO993372D0/no not_active Application Discontinuation
-
2000
- 2000-04-26 GR GR20000401000T patent/GR3033316T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS5539A (is) | 4-(2-ketó-1-bensímidazólinýl) píperidín efnasambönd sem mótlyf fyrir orl 1-viðtaka | |
| NO996484D0 (no) | Ny fremgangsmåte for fremstilling av paroxetin faststoffdispersjon | |
| ZA200107689B (en) | 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders. | |
| NO20012858D0 (no) | 4-(Aminometyl)-piperidin benzamider for behandling av gastrointestinale fortyrrelser | |
| NO20003211D0 (no) | Triazinforbindelser for behandling av CNS forstyrrelser | |
| NO993372D0 (no) | Substituerte 4-(6-fluor-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridin for behandling av CNS-forstyrrelser | |
| NO994258L (no) | Anvendelse av levobupivakain for behandling av ansiktsmigrene | |
| NO20026005L (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
| NO20011892D0 (no) | 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser | |
| PL328228A1 (en) | 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system | |
| HK1015363A1 (en) | Compounds analogous to thalidomide from the class comprising piperidine-2, 6-diones | |
| EE200000290A (et) | Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks | |
| NO20005424L (no) | Fremgangsmåte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer | |
| ID26573A (id) | Bentuk ke-vi dari 5, 6-dikloro-2-(isopropilamino) 1-(b-l-ribofurasonil)-1h-benzimidazol | |
| NO20030127L (no) | Indolderivater nyttige for behandling av CNS-forstyrrelser | |
| NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
| NO20026029L (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
| NO20005425L (no) | Fremgangsmåte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer | |
| ZA995212B (en) | The use of aryl-cyclohexylamine derivatives against CNS disorders. | |
| NO20026028L (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
| NO20005351D0 (no) | Paroksetin 10-kamfersulfonat for behandling av CNS lidelser | |
| NO20012028D0 (no) | Fremgangsmåte for fremstilling av 4-((2',5'-diamino-6'- halogenpyrimidin-4'-yl)amino)-cyclopent-2-enyl-metanoler | |
| DK2177517T3 (da) | Aminosubstitueret 2-(2,6-dioxopiperidin-3-yl)-phthalimid til at nedsætte TNF-alfa-niveauer | |
| HRP980497B1 (en) | NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES | |
| NO970190D0 (no) | Preparat til behandling av Parkinsons sykdom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |